SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

October 25, 2025 updated by: Massive Bio, Inc.
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The SYNERGY Registry is an international prospective, observational cohort study of eligible adult and pediatric pts with advanced solid and hematological malignancies, for whom the decision to consider CTE has already been made by their primary providers (PP). Using a proprietary application programming interface (API) linked to existing electronic health records (EHR) platforms, individual clinical data is extracted, analyzed and matched to a parametric database of existing institutional and non-institutional CT. Machine learning algorithms allow for dynamic matching based on CT allocation and availability for optimized matching. Patients voluntarily enroll into the registry, which is non-interventional with no protocol-mandated tests/procedures - all treatment decisions are made at the discretion of PP in consultation with their pts, based on the AI CT matching report, and VTB support. CTE will be assessed on variables including biomarkers, barriers to enrollment. Study duration anticipated as ~36 mo (~24-mo enrollment followed by 12 mo of data collection, to occur every 3 mo). The primary analysis will be performed 12 mo after last pt enrolled. The impact time to initiation of CTE on PFS and OS will be estimated by Kaplan-Meier and Cox multivariable survival analysis. Enrollment is ongoing, with a target of ≥50,000 patients.

Study Type

Observational

Enrollment (Estimated)

50000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Puerto Rico
      • San Juan, Puerto Rico, 00917
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
  • United States
    • Alabama
      • Birmingham, Alabama, United States, 35294
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Mobile, Alabama, United States, 36604
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Arizona
      • Scottsdale, Arizona, United States, 85260
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Arkansas
      • Little Rock, Arkansas, United States, 72205
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • California
      • Duarte, California, United States, 91010
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Irvine, California, United States, 92618
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • La Jolla, California, United States, 92093
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Orange, California, United States, 92868
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • San Francisco, California, United States, 94143
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Stanford, California, United States, 94305
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Denver, Colorado, United States, 80218
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Littleton, Colorado, United States, 80129
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Connecticut
      • Hartford, Connecticut, United States, 06102
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Norwalk, Connecticut, United States, 06856
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Delaware
      • Newark, Delaware, United States, 19713
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Florida
      • Jacksonville, Florida, United States, 32224
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Miami, Florida, United States, 33136
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Tampa, Florida, United States, 33612
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Georgia
      • Atlanta, Georgia, United States, 30322
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Savannah, Georgia, United States, 31405
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Idaho
      • Boise, Idaho, United States, 83706
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Illinois
      • Chicago, Illinois, United States, 60611
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Iowa
      • Iowa City, Iowa, United States, 52242
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Louisiana
      • New Orleans, Louisiana, United States, 70112
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Maine
      • Scarborough, Maine, United States, 04074
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Maryland
      • Baltimore, Maryland, United States, 21218
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Bethesda, Maryland, United States, 20892
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Silver Spring, Maryland, United States, 20904
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Towson, Maryland, United States, 21204
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Massachusetts
      • Worcester, Massachusetts, United States, 01655
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Lansing, Michigan, United States, 48912
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Minnesota
      • Duluth, Minnesota, United States, 55805
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Mississippi
      • Hattiesburg, Mississippi, United States, 39401
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Missouri
      • Kansas City, Missouri, United States, 64111
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • St Louis, Missouri, United States, 63110
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Montana
      • Billings, Montana, United States, 59102
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Nebraska
      • Omaha, Nebraska, United States, 68124
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • New Jersey
      • New Brunswick, New Jersey, United States, 08901
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • New Mexico
      • Albuquerque, New Mexico, United States, 87131
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • New York
      • Buffalo, New York, United States, 14263
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Hempstead, New York, United States, 11042
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Manhasset, New York, United States, 11030
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • New York, New York, United States, 10006
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Staten Island, New York, United States, 10314
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • North Carolina
      • Chapel Hill, North Carolina, United States, 27514
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Winston-Salem, North Carolina, United States, 27157
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • North Dakota
      • Fargo, North Dakota, United States, 58102
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Ohio
      • Cincinnati, Ohio, United States, 45219
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Columbus, Ohio, United States, 43210
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Mayfield Heights, Ohio, United States, 44124
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Oklahoma
      • Tulsa, Oklahoma, United States, 74146
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Oregon
      • Portland, Oregon, United States, 97239
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19044
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Rhode Island
      • Providence, Rhode Island, United States, 02903
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • South Carolina
      • Greenville, South Carolina, United States, 29605
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Tennessee
      • Memphis, Tennessee, United States, 38105
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Nashville, Tennessee, United States, 37203
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Texas
      • Dallas, Texas, United States, 75246
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Houston, Texas, United States, 77030
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
      • Temple, Texas, United States, 76508
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Utah
      • Salt Lake City, Utah, United States, 84112
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Virginia
      • Charlottesville, Virginia, United States, 22908
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Washington
      • Seattle, Washington, United States, 98109
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • West Virginia
      • Morgantown, West Virginia, United States, 26506
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:
    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53226
        • Recruiting
        • Massive Bio SYNERGY-AI site
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Observational cohort study of eligible adult and pediatric pts with advanced solid and hematological malignancies, for whom the decision to consider clinical trial enrollment (CTE) has already been made by their primary providers (PP).

Description

Inclusion Criteria:

  • Pts with solid and hematological malignancies;
  • Pts cancer-related biomarkers, gene variants, fusion and rearrangements (by immunohistochemistry, PCR, FISH or NGS): PD-L1, MSI (MMR), Claudin18.2, HER2/Neu, Tumor mutational burden/load (TMB), ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, APC, AR, ATM, ATRX, AURKA, AURKB, BAP1, BCL2, BCL6, BRAF, BRCA1, BRCA2, BTK, CCND1, CCND2, CCND3, CDK4, CDK6, CDKN1A/B, CEBPA, CHEK1, CHEK2, CSF1R, CTNNB1, DAXX, DDR1/2, DNMT3A, EGFR, ERBB2, ERBB3, ERBB4, ERCC4, ER, ESR1, FANCA, FAS, FBXW7, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, GATA3, GATA6, GNAS, HDAC1, HGF, HRAS, IDH1, IDH2, IGF1R, JAK1, JAK2, JAK3, KDR (VEGFR2), KIT, KRAS, MAP2K2 (MEK2), MAP3K1, MCL1, MDM2, MDM4, MEN1, MET, MSH2, MSH3, MSH6, MTOR, MUTYH, MYC, MYCL (MYCL1), NF1, NF2, NOTCH1, NPM1, NRAS, NTRK1, NTRK2, NTRK3, PALB2, PARP1, PARP2, PARP3, PBRM1, PDCD1 (PD1), PDCD1LG2 (PD-L2), PDGFRA, PDGFRB, PIK3C, PMS2, POLD1, POLE, PRDM1, PTCH1, PTEN, RAF1, RB1, RET, RICTOR, ROS1, RPTOR, SDHA/B/C, SMAD, SMARC, SMO, STK11, TGFBR2, TP53, TSC1, TSC2, VEGFA, VHL, WT1, ZNF217, ZNF703, CEACAM, NRG1, among others.

These biomarkers should be determined by local laboratory, external vendor, or next generation sequencing platform

  • Decision to consider clinical trial pre-screening enrollment (CTE) by primary provider and/or patient

Exclusion Criteria:

  • ECOG PS > 2;
  • Abnormal organ function;
  • Hospice enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study Group
Eligible adult and pediatric pts with advanced solid and hematological malignancies, for whom the decision to consider CTE has already been made by their primary providers (PP).
Other: Clinical Trial Matching
Using a proprietary application programming interface (API) linked to existing electronic health records (EHR) platforms, individual clinical data is extracted, analyzed and matched to a parametric database of existing institutional and non-institutional CT. Machine learning algorithms allow for dynamic matching based on CT allocation and availability for optimized matching.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients Eligible for CTE versus Actual CTE
Time Frame: Through study completion, an average of 1 year
CTE Accrual
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of CTE on Overall Survival (OS), estimated by Kaplan-Meier and Cox multivariable survival analysis
Time Frame: 4 years
OS
4 years
Impact of CTE on Progression-Free Survival (PFS), estimated by Kaplan-Meier and Cox multivariable survival analysis
Time Frame: 4 years
PFS
4 years
Identification of Barriers to CTE
Time Frame: Through study completion, an average of 1 year
To identify barriers to accruals to clinical trials, as measured and reported by a questionnaire
Through study completion, an average of 1 year
Real World Data Analytics
Time Frame: Through study completion, an average of 1 year
To Analyze Individual Standard of Care Chemotherapy Utilization (nominal), across treatment lines (numeric); data will be combined and aggregated to report chemotherapy utilization rate (%).
Through study completion, an average of 1 year
Virtual Tumor Board Utilization
Time Frame: Through study completion, an average of 1 year
VTB Use Rate
Through study completion, an average of 1 year
Time from Intervention to Actual CTE (months)
Time Frame: Through study completion, an average of 1 year
Time to CTE
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Massive Bio, Inc.

Investigators

  • Principal Investigator: Selin Kurnaz, PhD, Massive Bio, Inc.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Estimated)

December 1, 2038

Study Completion (Estimated)

June 1, 2040

Study Registration Dates

First Submitted

February 13, 2018

First Submitted That Met QC Criteria

February 24, 2018

First Posted (Actual)

March 2, 2018

Study Record Updates

Last Update Posted (Estimated)

October 28, 2025

Last Update Submitted That Met QC Criteria

October 25, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SYNERGY-AI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Melanoma

Clinical Trials on Clinical Trial Matching

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe